Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Pemberdayaan kader tangguh peduli lepra dalam pelacakan kusta

Kurniadi K, Aniharyati A, Haris A. LPPM Universitas Abdurrab. Jurnal Pengabdian Masyarakat Multidisiplin. 2023; 7 (1) : 64-71.
Download PDF
Publication

Single-nucleotide polymorphism of interleukin-10 promoter (IL-10 -819C/T) in leprosy patients with and without erythema nodosum leprosum, and household contacts

Arif SM, Massi N. Narra T. Narra J. 2023; 3 (3) : e276.
Download PDF
Publication

Redesigning multi-drug therapy: Hasty or judicious?

Sagar HK, Singh Pawar H. Scientific Scholar. Indian Journal of Dermatology, Venereology and Leprology. 2023;
Download PDF
Publication

Respuesta inmune en pacientes con diagnóstico de lepra

Darias-Domínguez C, Velázquez-Sánchez A, De Vegas-Ascanio L, et al. Revista Médica Electrónica. 2023;
Download PDF
Publication

Metformin as adjunctive therapy in combination with multidrug treatment for multibacillary leprosy: A protocol for a randomized double-blind, controlled Phase 2 trial in Indonesia (MetLep Trial)

Krismawati H, Muchtar SV, Rahardjani M, et al. F1000 Research Ltd. Wellcome Open Research. 2023;
Download PDF
Practical material

Pepra med lepra - siste nytt frå leprafronten

Pestpodden . 2023;
Access resource
Publication

Discapacidad por lepra

Gascón L. C. H.. Folia Dermatológica Cubana. 2023; 17 (1) : 1-6.
Download PDF
Publication

Assessment of knowledge and awareness about leprosy among medical college students in Tripoli

Amer H, Hariba Z. Journal of Science and Technology - Awlad Ali. 2023;
Download PDF
Publication

Adesão ao tratamento de Hanseníase no município de Itumbiara - GO

Rocha LA, Vicente DAR, Da Cunha LLP, et al. South Florida Publishing LLC. Brazilian Journal of Health Review. 2023; 6 (5) : 24869-24883.
Download PDF
Publication

A persistência da hanseníase no brasil: problemas na detecção precoce ou falta de interesse das políticas de saúde?

Erpen G. G, Bevilaqua J. F, Xavier P. B. Seminário de Iniciação Científica e Seminário Integrado de Ensino, Pesquisa e Extensão (SIEPE). 2023;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 130
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD